Veraxa Biotech Holding AG

VRXA ·Healthcare, Drug Manufacturers - General
Valuation Reverse DCF

Reverse DCF isn’t available yet

Not enough filings data to compute a starting per-share figure for VRXA (needs operating cash flow/capital expenditures, or diluted EPS as a fallback, for at least one recent quarter or fiscal year).